In pharmaceutical and biotech regulatory document development, your content strategy – the business plan for how you create, manage, and deliver content – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market.
Content automation is the practice of using systems to perform repetitive tasks to create content; such as formatting, data retrieval, and document assembly. Content automation in the pharmaceutical industry is often implemented for the following reasons:
Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.
There are many reasons why a component structured content management (SCM) system is superior to using a Microsoft Word document for managing your Company Core Data Sheet (CDS or CCDS). We touched upon some of the reasons in our previous blog post, The CDS is Dead! Long Live the CDS!
The Company Core Data Sheet (CDS or CCDS) is one of the most important documents a pharmaceutical company creates. The CDS is a working document that contains information about the pharmaceutical product. It includes information from multiple sources, such as clinical trial data systems, clinical report documents, CMC data systems,